Table 45.
Country | Total number of E. coli tested | Number subjected to supplementary testing and number resistant | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cefotaxime | Ceftazidime | Cefoxitin | Cefepime | Ertapenem | Temocillin | ||||||||
N | n Res | N | n Res | N | n Res | N | n Res | N | n Res | N | n Res | ||
Austria | 163 | 4 | 3 | 4 | 3 | 4 | 0 | 4 | 3 | 4 | 0 | 4 | 0 |
Belgium | 186 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 0 | 2 | 0 |
Cyprus | 55 | 4 | 3 | 4 | 3 | 4 | 1 | 4 | 3 | 4 | 0 | 4 | 0 |
Czech Republic | 187 | 5 | 5 | 5 | 4 | 5 | 3 | 5 | 2 | 5 | 0 | 5 | 0 |
Estonia | 85 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
France | 200 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 |
Germany | 212 | 8 | 7 | 8 | 6 | 8 | 2 | 8 | 5 | 8 | 0 | 8 | 0 |
Greece | 116 | 6 | 6 | 6 | 6 | 6 | 0 | 6 | 6 | 6 | 0 | 6 | 0 |
Hungary | 170 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 0 | 2 | 0 |
Ireland | 147 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
Netherlands | 298 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
Poland | 170 | 9 | 7 | 9 | 6 | 9 | 0 | 9 | 6 | 9 | 0 | 9 | 0 |
Portugal | 198 | 10 | 10 | 10 | 10 | 10 | 0 | 10 | 10 | 10 | 0 | 10 | 0 |
Romania | 399 | 6 | 6 | 6 | 6 | 6 | 2 | 6 | 5 | 6 | 0 | 6 | 0 |
Spain | 170 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 |
Sweden | 200 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 |
Total (MSs 16) | 2,956 | 63 | 56 | 63 | 53 | 63 | 12 | 63 | 45 | 63 | 0 | 63 | 0 |
Norway | 270 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | 0 | 2 | 0 |
Switzerland | 182 | 4 | 0 | 4 | 0 | 4 | 0 | 4 | 0 | 4 | 0 | 4 | 0 |
No E. coli isolates from fattening pigs were resistant to meropenem. Cyprus reported the presence of one isolate resistant to imipenem.
Interpretive cut‐off applied for temocillin: > 32 mg/L.
ECOFFs: epidemiological cut‐off values; N: number of the isolates tested; n Res: number of the isolates resistant; MSs: Member States.